Sebastian BioPharma
PrivateLast Round
Accelerator
Jun 1, 2025
Total Funding Raised
$8.53M
Company Overview
Sebastian BioPharma is a preclinical-stage biotechnology company that develops tumor-targeted, multi-pathway therapeutics for immunotherapy-resistant solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sebastian BioPharma Comparables
Compare Sebastian BioPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tallac Therapeutics | 73% | |
| Gilead Sciences | 69% | |
| Replicate Bioscience | 67% | |
Sebastian BioPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 1, 2025 |
Sebastian BioPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pathfinder Venture Capital | Angel |
| SCbioDrive | Accelerator |
Sebastian BioPharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sebastian BioPharma's valuation, stock price, and market status.